Malignant Melanoma Archive - Seite 9 von 19 - IOZK

Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients

2011-07-19/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-07-19 / Clin. Cancer Res. 2011 Sep;17(17):5725-35

Dendritic cell (DC) vaccination with low dose temozolomide phase I/II trial in melanoma patients: Preliminary data on peripheral blood regulatory t-cells (Treg) and DC-TEM8 expression modulations.

2011-06-17/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-06-17 / J Clin Oncol 29: 2011 (suppl; abstr e13029)

Melanoma patients treated with dendritic cell vaccination, interleukin-2, and metronomic cyclophosphamide: Results from a phase II trial.

2011-06-04/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr e13084)

Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2

2011-03-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-03-01 / Scand. J. Immunol. 2011 Mar;73(3):222-33

Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma

2011-02-10/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-02-10 / Gene Ther. 2011 Jun;18(6):584-93

New approaches to the development of adenoviral dendritic cell vaccines in melanoma

2010-12-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-12-01 / Curr Opin Investig Drugs 2010 Dec;11(12):1399-408

Wild-type and modified gp100 peptide-pulsed dendritic cell vaccination of advanced melanoma patients can lead to long-term clinical responses independent of the peptide used

2010-11-11/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-11-11 / Cancer Immunol. Immunother. 2011 Feb;60(2):249-60

Resistance to the proapoptotic effects of interferon-gamma on melanoma cells used in patient-specific dendritic cell immunotherapy is associated with improved overall survival

2010-10-20/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-10-20 / Cancer Immunol. Immunother. 2011 Jan;60(1):123-31

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

2010-10-01/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-10-01 / Cytotherapy 2010 Oct;12(6):721-34

Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma

2010-09-27/in Dendritic Cells, International Publications, Malignant Melanoma /von 2010-09-27 / J Transl Med 2010 Sep;8:89